Remote stereocontrol in catalytic asymmetric reactions is a major challenge in modern organic synthesis.[@b1], [@b2] Recently, asymmetric organocatalysis has been successfully applied to the functionalization of unsaturated carbonyl compounds at their γ-, δ-, and ε-positions with high stereo- and site-selectivity.[@b1] The two basic activation strategies exploit LUMO-lowering and HOMO-raising effects, whereby iminium ions and either di- or trienamines are formed by condensation of the carbonyl substrates with the amine function of chiral organocatalysts.[@b1], [@b3] Melchiorre and co-workers achieved the δ-functionalization of enones by using a cinchona-based primary amine, which forms an iminium ion with the polyunsaturated carbonyl substrate, thus delivering the LUMO-lowering effect through the conjugated π system.[@b4] Enamine catalysis[@b5] was also successfully applied to vinylogous systems. Di- and trienamine catalysis,[@b5],[@b5] usually employing chiral secondary amines to activate the γ and ε sites of unsaturated aldehydes, has led for instance to a series of Diels--Alder cycloadditions[@b5] and other remote functionalization reactions.[@b6]

In most studies a single vinylogous substrate, either the electrophilic or nucleophilic partner, was used.[@b1], [@b3]--[@b7] In 2013 Jørgensen and co-workers reported the first organocatalytic doubly vinylogous Michael-type reaction, namely the 1,6-addition of alkylidene lactones to 2,4-dienals with the formation of a new stereocenter (Scheme [1a](#sch01){ref-type="scheme"}).[@b8] It is significantly difficult to simultaneously activate the two vinylogous partners at their remote reactive sites whilst achieving high regio-, diastereo-, and enantiocontrol. Indeed, to the best of our knowledge there are no precedents for the catalytic, asymmetric doubly vinylogous Michael addition (DVMA) to 2,4-dienones, the much less reactive analogues of 2,4-dienals. The realization of such a reaction would prove the broad applicability of the organocatalytic vinylogous activation patterns, thus representing a significant advance in the field. Moreover, asymmetric doubly vinylogous reactions naturally leave two unsaturated C--C bonds in the product and provide a potential opportunity for additional transformations for the construction of complex chiral molecules.

![a) First asymmetric organocatalytic doubly vinylogous Michael addition. b) Use of α,β-unsaturated γ-butyrolactams in vinylogous Michael additions. c) This work: unprecedented asymmetric organocatalytic DVMA and a related cascade between α,β-unsaturated γ-butyrolactams and dienones. Boc=*tert*-butoxycarbonyl.](anie0054-10249-f1){#sch01}

Herein we report the first doubly vinylogous Michael addition to 2,4-dienones by using a diamine derived from *tert*-leucine as an organocatalyst (Scheme [1c](#sch01){ref-type="scheme"}).[@b9] The challenging γ to δ 1,6-addition reaction of N-protected α,β-unsaturated γ-butyrolactams[@b10] to sterically congested β-substituted cyclic dienones proceeds with high regio- and stereoselectivity wherein strong hydrogen-bonding interactions between the N-protected, deprotonated butyrolactam and the catalyst are believed to be responsible for the observed control. In addition we report that by using 3-alkenyl cyclopent-2-enones as substrates, the initial DVMA is followed by a vinylogous Michael addition/isomerization cascade, thus affording tricyclic γ-lactams with four new stereocenters.

Our investigations began with a screen of a set of chiral diamines (**3 a--d**) in the DVMA of the dienone **1 a** and the N-protected α,β-unsaturated γ-butyrolactam **2 a** as shown in Table [1](#tbl1){ref-type="table"}. The [l]{.smallcaps}-*tert*-leucine derivative **3 d** afforded the desired product **4 a** with encouraging conversion and good stereoselectivity (entry 4). This catalyst performed well in most solvents, but provided the best *ee* values in chlorinated solvents (89--91 % *ee*, entries 4--6), compared to the 85 % *ee* obtained with ethers and the less than 80 % *ee* obtained with polar solvents (see Table S1 in the Supporting Information). An extensive screening of acidic additives (see Table S2 in the Supporting Information) allowed identification of *p*-anisic acid as ideal. By using 20 mol % of *p*-anisic acid in CH~2~Cl~2~ at 4 °C, the product was obtained with 19:1 d.r. and 91 % *ee* (Table [1](#tbl1){ref-type="table"}, entry 13; see Tables S3--S6 in the Supporting Information for full optimization studies). Finally, by increasing the amount of *p*-anisic acid to 40 mol % and adjusting the dienone/butyrolactam ratio to 2:1, the d.r. and *ee* values were slightly increased (entry 14). When the reaction was run under these optimized reaction conditions for 60 hours, the desired product was obtained with 95 % yield upon isolation, in greater than 19:1 d.r. and 91 % *ee* (see Table [2](#tbl2){ref-type="table"}).

###### 

Catalyst screening and optimization of the doubly vinylogous Michael addition (DVMA) between 1 a and 2 a.[\[a\]](#tf1-1){ref-type="table-fn"}

![](anie0054-10249-for001)

  Entry                                                                     Cat.      Solvent      Conv. \[%\][\[b\]](#tf1-2){ref-type="table-fn"}   d.r.[\[b\]](#tf1-2){ref-type="table-fn"}   *ee* \[%\][\[c\]](#tf1-3){ref-type="table-fn"}
  ------------------------------------------------------------------------- --------- ------------ ------------------------------------------------- ------------------------------------------ ------------------------------------------------
  1                                                                         **3 a**   CDCl~3~      16                                                4:1                                        −7
  2                                                                         **3 b**   CDCl~3~      trace                                             n.d.                                       n.d.
  3                                                                         **3 c**   CDCl~3~      trace                                             n.d.                                       n.d.
  4                                                                         **3 d**   CDCl~3~      55                                                7:1                                        89
  5                                                                         **3 d**   CH~2~Cl~2~   74                                                19:1                                       90
  6                                                                         **3 d**   1,2-DCE      88                                                12:1                                       91
  7                                                                         **3 d**   toluene      96                                                9:1                                        79
  8                                                                         **3 d**   MTBE         95                                                7:1                                        82
  9                                                                         **3 d**   EtOAc        86                                                6:1                                        86
  10                                                                        **3 d**   *i-*PrOH     65                                                2:1                                        79
  11[\[d](#tf1-4){ref-type="table-fn"},[e\]](#tf1-5){ref-type="table-fn"}   **3 d**   1,2-DCE      86                                                16:1                                       91
  12[\[d\]](#tf1-4){ref-type="table-fn"}                                    **3 d**   CH~2~Cl~2~   91                                                19:1                                       89
  13[\[d](#tf1-4){ref-type="table-fn"},[e\]](#tf1-5){ref-type="table-fn"}   **3 d**   CH~2~Cl~2~   76                                                19:1                                       91
  14[\[e](#tf1-5){ref-type="table-fn"},[f\]](#tf1-6){ref-type="table-fn"}   **3 d**   CH~2~Cl~2~   88                                                \>19:1                                     92

Reactions performed using 1.0 equiv of **2 a** (0.15 mmol, 0.5 [m]{.smallcaps}), 1.5 equiv of **1 a**, 0.2 equiv of catalyst **3**, and 0.2 equiv of PhCO~2~H at 25 °C for 24 h, unless otherwise stated.

Conversion and d.r. values determined by ^1^H NMR analysis of the crude reaction mixture.

Determined by HPLC analysis using a chiral stationary phase.

With 0.2 equiv of *p*-anisic acid.

Reaction performed at 4 °C for 48 h.

With 0.4 equiv of *p*-anisic acid and 2.0 equiv of **1 a**. 1,2-DCE=1,2-dichloroethane, MTBE=methyl *tert*-butyl ether.

Next, the scope of the asymmetric DVMA with respect to dienone reaction partners was explored. By using the N-Boc-protected γ-butyrolactam **2 a** as the reacting partner, an extensive range of 3-alkenyl cyclohex-2-enones were transformed into the desired products **4** with good to excellent stereoselectivity (Table [2](#tbl2){ref-type="table"}). Aryl-substituted dienones with electron-donating substituents in the *para*- and *meta*-positions of the aromatic ring gave excellent enantioselectivities and diastereoselectivities (**4 b**,**c**,**f**), whilst substrates with substituents in the *ortho*-position resulted in a slightly diminished *ee* value (**4 d**,**e**). The enantioselectivity remained excellent when the aryl ring bore electron-withdrawing and halogen substituents (**4 g**--**j**), although in the presence of the nitro group the d.r. value was reduced. Also, less reactive aliphatic substituted dienones (**4 k**,**l**) and bulky substrates with gem-dimethyl groups on the cyclohexenone (**4 m**,**n**) were well-tolerated. The absolute configuration of **4 p** was determined by X-ray crystallographic analysis.[@b11]

###### 

Scope of the DVMA with respect to the dienones.[\[a\]](#tf2-1){ref-type="table-fn"}

  --
  --

Reactions performed using 1.0 equiv of **2** (0.2 mmol, 0.5 [m]{.smallcaps}), 2.0 equiv of **1**, 0.2 equiv of **3 d**, and 0.4 equiv of *p-*anisic acid in CH~2~Cl~2~ at 4 °C. Yields of isolated products are given. The d.r. values were determined by ^1^H NMR analysis of the crude reaction mixture. The *ee* values were determined by HPLC analysis using a chiral stationary phase.

The reaction was scaled up to obtain 1.06 grams of **4 a** (Scheme [2](#sch02){ref-type="scheme"}). By lowering the catalyst loading to 10 mol %, raising the temperature to 25 °C, and prolonging the reaction time to 72 hours the yield of the isolated product (93 %) and enantioselectivity (90 % *ee*) were comparable to those obtained on smaller scale.

![Large-scale preparation of 4 a.](anie0054-10249-fig2){#sch02}

N-Ts- and N-Cbz-protected α,β-unsaturated γ-butyrolactams were also compatible with the reaction conditions (Table [3](#tbl3){ref-type="table"}, **4 q**--**4 v**). Compared to N-Boc-protected substrates, the enantioselectivity remained good (83--91 % *ee*). However the yields (45--72 %) and diastereoselectivities (7:1 to 10:1 d.r.) were slightly diminished.

###### 

Scope of the DVMA with respect to the N-protected α,β-unsaturated γ-butyrolactams.^\[a\]^

  --
  --

Reactions performed using 1.0 equiv of **2** (0.2 mmol, 0.5 [m]{.smallcaps}), 2.0 equiv of **1**, 0.2 equiv of **3 d**, and 0.2 equiv *p*-anisic acid in CH~2~Cl~2~ at 4 °C, unless otherwise stated. Yields of isolated products are given. The d.r. values were determined by ^1^H NMR analysis of the crude reaction mixture. The *ee* values were determined by HPLC analysis using a chiral stationary phase. \[b\] Reaction performed at RT. Cbz=carboxybenzyl, Ts=4-toluenesulfonyl.

Interestingly, when switching from six- to five-membered cyclic dienones, a doubly vinylogous Michael addition/vinylogous Michael addition/isomerization cascade resulted (Table [4](#tbl4){ref-type="table"}). The cascade reaction proceeded with excellent enantioselectivity (92--99 % *ee*), but poor to moderate diastereoselectivity (d.r. from 1:1 to 5:1). In our proposed mechanism for the cascade reaction (Scheme [3](#sch03){ref-type="scheme"}), the initial DVMA is followed by a vinylogous Michael addition from the γ-position of the cyclopentenone to the β-position of the butyrolactam. Migration of the C--C double bond to the other side of the carbonyl group may be ascribed to an isomerization via the dienamine of cyclopentenone,[@b12] presumably driven by the thermodynamic stability of the product **6**.

![Postulated mechanism for the cascade reaction.](anie0054-10249-f3){#sch03}

###### 

Scope of the cascade reaction between 3-alkenyl cyclopent-2-enones and N-protected α,β-unsaturated γ-butyrolactams.^\[a\]^

  --
  --

\[a\] Reactions performed using 1.0 equiv of **2** (0.2 mmol, 0.5 [m]{.smallcaps}), 2.0 equiv of **5**, 0.3 equiv of **3 d**, and 0.3 equiv *p-*anisic acid in CH~2~Cl~2~ at 4 °C for 4 days. Yields of the isolated products are given. The d.r. values were determined by ^1^H NMR analysis of the crude reaction mixture. The *ee* values were determined by HPLC analysis using a chiral stationary phase.

This mechanism is supported by the outcomes of the intermolecular vinylogous additions of 3-phenylcyclopent-2-enone (**7 a**) and 3-phenylcyclohex-2-enone (**7 b**) to the α,β-unsaturated γ-butyrolactam **2 a** (Scheme [4](#sch04){ref-type="scheme"}). A vinylogous Michael addition between **7 a** and **2 a**, which mimics the second step of the reaction cascade, took place with 30 mol % catalyst at 40 °C in 43 % yield. On the contrary, no reaction was observed using **7 b**.

![Vinylogous Michael addition.](anie0054-10249-f4){#sch04}

The relative stereochemical configuration of the products of the cascade reaction (Table [4](#tbl4){ref-type="table"}) was determined by single-crystal X-ray analysis of the compound **6 d**. The absolute configuration was assigned by analogy with that determined for the six-membered ring analogues, under the assumption that 3-alkenyl cyclopent-2-enones undergo the DVMA with the same enantiofacial selectivity.

In conclusion, we have developed a novel asymmetric direct doubly vinylogous Michael addition between α,β-unsaturated γ-butyrolactams and sterically congested β-substituted cyclic dienones, affording products with significant levels of diastereo- and enantioselectivity. Remote transmission of the stereochemical information was successfully realized through the two conjugated π systems by taking advantage of a bifunctional diamine catalyst. In addition, this method has provided access to chiral tricyclic γ-lactams with up to four newly formed stereocenters, generated from 3-alkenyl cyclopentenones substrates by an unprecedented vinylogous Michael addition/vinylogous Michael addition/isomerization cascade.
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